Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate

26 Feb 2021

Abstract excerpt

ABSTRACT: Ovarian cancer (OC) is the leading cause of gynecological cancer deaths. Extraordinary histologic and genetic heterogeneity presents as great hurdle to OC's diagnosis and treatment. MRPS12 (Mitochondrial Ribosomal Protein S12), encoding a 28S subunit protein, controls the decoding fidelity and susceptibility to aminoglycoside antibiotics. Our study aims to investigate the clinical significance and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33663122
DOI: 10.1097/md.0000000000024898

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidatePMID 33663122Read ↗

MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes.Semantic proximity Read ↗

Mitochondrial ribosomal proteins: potential targets for cancer prognosis and therapySemantic proximity Read ↗

Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.Semantic proximity Read ↗

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancerSemantic proximity Read ↗

Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancerSemantic proximity Read ↗

Pan-cancer analysis of the oncogenic effects of ribosomal protein L13 (MRPL13) and validation in hepatocellular carcinomaSemantic proximity Read ↗

A multidimensional analysis of MRPL17 protein in human tumorsSemantic proximity Read ↗

Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian CancerSemantic proximity Read ↗

The role of mitochondrial genes in the prognosis of ovarian cancer: new insights from bioinformaticsSemantic proximity Read ↗

MRPS23 is a novel prognostic biomarker and promotes glioma progression.Semantic proximity Read ↗

Construction of a mitochondria genes-based model for prognosis prediction, drug guidance and immune feature analysis in ovarian serous cystadenocarcinomaSemantic proximity Read ↗

The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.